HILT for Meralgia Paresthetica

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 8, 2024

Study Completion Date

September 8, 2024

Conditions
Meralgia ParestheticaLateral Femoral Cutaneous Nerve Entrapment
Interventions
DEVICE

High-Intensity Laser Therapy (HILT)

Participants will undergo HILT treatment using a diode laser device (wavelength: 1064 nm; power: 12 W; peak power: 50 W; energy density: 600 J/cm²; spot size: 1 cm²; pulse duration: 200 μs; pulse frequency: 10 Hz) applied in continuous mode. The laser probe will make contact with the skin over the LFCN entrapment site at three specific points: (a) the inguinal ligament, (b) the point of maximum tenderness along the nerve pathway, and (c) the mid-point between the ASIS and the lateral border of the patella. Each point will be treated for 1 minute and 40 seconds, totaling a 5-minute session. Participants will undergo 12 sessions in total, with three sessions per week for four weeks.

DEVICE

Sham High-Intensity Laser Therapy (Sham HILT)

Participants will undergo sham HILT treatment using an identical laser device with no active laser output, following the same treatment protocol as the HILT group. The laser probe will make contact with the skin over the LFCN entrapment site at the same three specific points as the HILT group. Each point will be treated for 1 minute and 40 seconds, totaling a 5-minute session. Participants will undergo 12 sessions in total, with three sessions per week for four weeks.

Trial Locations (1)

3221405

Outpatient clinic of faculty of physical therapy, Ahram Canadian University, Al Ḩayy Ath Thāmin

All Listed Sponsors
lead

Ahram Canadian University

OTHER

NCT05893732 - HILT for Meralgia Paresthetica | Biotech Hunter | Biotech Hunter